SIM
GSK icon

Sentry Investment Management’s GSK GSK Stock Holding History

Sentry Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-14,320
Closed -$898K – 529
2013
Q3 		$898K Hold
14,320
– – 0.05% 261
2013
Q2 		$894K Buy
+14,320
New +$909K 0.05% 175

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sentry Investment Management's GSK Position: Q4 2013 in Review

Sentry Investment Management sold out of GSK (GSK) in Q4 2013, closing a stake of 14,320 shares — an estimated $898K sold.

Sentry Investment Management first reported a position in GSK in Q2 2013 and held it in 2 quarters. The position peaked at $898K in Q3 2013. 681 funds tracked by Wall St. Rank hold GSK as of Q4 2013.

  • Sentry Investment Management reported no remaining GSK position as of Q4 2013 after selling out during the quarter.
  • Sentry Investment Management sold 14,320 GSK shares in Q4 2013, an estimated $898K.
  • Sentry Investment Management first reported a position in GSK in Q2 2013 and held it in 2 quarters.
  • Sentry Investment Management's GSK position peaked at $898K in Q3 2013.
  • 681 funds tracked by Wall St. Rank held GSK as of Q4 2013.

Based on Sentry Investment Management's 13F filing for Q4 2013, filed 10 Feb 2014.